EvolveImmune Therapeutics is a next-generation immunotherapy platform company based in Farmington and Branford, CT.  Building upon research that originates from the Sidi Chen Lab at Yale University, EvolveImmune is leveraging a novel in vivo target discovery platform to develop a broad portfolio of first-in-class molecules for unmet needs in oncology and autoimmune diseases.

Biotechnology

EvolveImmune Therapeutics

EvolveImmune Therapeutics' headquarters in Branford, CT, United States

Stephen Bloch

Mark Aimone, MBA

Jeremy Myers

Jay Fine

Michael Franken M.D.

Jennifer Gabler

Louis Matis

Charles Fuchs

Ian Taylor

Derek Yoon

Sidi Chen

Nils Lonberg

Mario Sznol

Susan Kaech

Daguang Wang

Denis Patrick

Richard Flavell

The Research and Development team at EvolveImmune Therapeutics drives the innovation of novel immunotherapeutic molecules by leveraging cutting-edge in vivo target discovery platforms. Comprised of scientists and researchers of various specializations, the team focuses on identifying and optimizing therapeutic candidates to address unmet needs in oncology and autoimmune diseases, translating groundbreaking research into clinical applications.

Research and Development

The Directors and Senior Management team at EvolveImmune Therapeutics is responsible for strategic oversight and executive decision-making. They guide the company's research and development initiatives, manage key operations like CMC (Chemistry, Manufacturing, and Controls), and ensure the alignment of organizational goals with pioneering advancements in immunotherapy. This team leverages its expertise to steer the company towards impactful innovations in oncology and autoimmune disease treatments.

Directors and Senior Management

The Leadership Team at EvolveImmune Therapeutics is responsible for setting the strategic direction of the company, overseeing the development and commercialization of innovative immunotherapy solutions. This diverse group of founders and executives collaborates to align research initiatives with market needs, secure funding, and navigate regulatory landscapes, ensuring the advancement of cutting-edge treatments addressing critical challenges in oncology and autoimmune diseases.

Leadership Team

The Advisory Team at EvolveImmune Therapeutics comprises a group of experts who provide strategic guidance and insights on scientific research, clinical development, and regulatory strategies. Their collective expertise helps steer the company's efforts in developing groundbreaking immunotherapies for oncology and autoimmune diseases.

��

EvolveImmune Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Directors and Senior Management

Leadership Team

Advisory Team

Offices

��������

EvolveImmune Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Directors and Senior Management

Leadership Team

Advisory Team

Offices

Related companies

��